Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
The second podcast from Dr. Ramalingam's excellent webinar on Personalizing Treatment for First Line NSCLC is the question and answer session that followed it, which includes many questions about EGFR-based therapy, antiangiogenic agents, and other relevant issues for individualized treatments for patients.
Here is the audio and video versions of the podcast, along with the figures and transcript for it.
[powerpress]
ramalingam-personalizing-first-line-nsclc-therapy-qa-transcript
ramalingam-personalizing-first-line-nsclc-therapy-qa-transcript
ramalingam-personalizing-first-line-nsclc-therapy-qa-figures
Many thanks to Dr. Ramalingam, who donated his time and effort rather than accept the offered honorarium, and to Eli Lilly Oncology for providing the educational grant that supported this webinar and podcast.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi amitchouhan,
Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...
I was searching for this, Thank you so much for the info.